Retinal Endovascular Lysis in Ischemic Central Retinal Vein Occlusion
Purpose Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent is injected directly into a cannulated retinal vein after pars plana vitrectomy. Design Prospective interventional case series. Participants...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 114; no. 4; pp. 716 - 723.e1 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent is injected directly into a cannulated retinal vein after pars plana vitrectomy. Design Prospective interventional case series. Participants Thirteen strictly defined patients with ischemic CRVO. Methods Patients with a decimal visual acuity (VA) of 0.2 or worse were scheduled for surgery within the first 5 months after onset of CRVO. A full ocular examination, determination of VA (Early Treatment Diabetic Retinopathy Study charts), and fluorescein angiography were done preoperatively and 6, 12, 26, and 52 weeks postoperatively. Main Outcome Measure Visual acuity 1 year after retinal endovascular lysis. Secondary study end points were (1) correlation of VA and successful recombinant tissue plasminogen activator injection into a retinal vein, (2) complication rate, and (3) number of additional surgical procedures within the first year after retinal endovascular lysis. Results All patients had an ischemic CRVO and completed the 1-year follow-up visit. Preoperative decimal VA was 0.063 +0.025/−0.018 (VA range, light perception [LP]–0.2); 6-week postoperative VA, 0.049 +0.024/−0.016 (LP–0.4); 3-month postoperative VA, 0.043 +0.019/−0.014 (LP–0.3); 6-month postoperative VA, 0.035 +0.022/−0.013 (blindness–0.4); and 12-month postoperative VA, 0.04 +0.026/−0.016 (blindness–0.4). Visual acuity changed 1 year after retinal endovascular lysis by −1.923±1.619 lines (+6 to −16 lines; P = 0.258). We considered the retinal endovascular lysis procedure to have been technically successful in 10 eyes. Visual changes did not depend on successful lysis. Six eyes developed neovascular glaucoma, of which 2 globes ended up with painful phthisis and had to be removed. Retinal detachment was found in 3 eyes and cataract in 4. Together, the 13 eyes needed 22 additional surgical procedures. Preoperative and postoperative angiographic examinations showed no significant changes. Conclusion Ischemic CRVO patients did not profit from retinal endovascular lysis in this pilot study. Visual results and the risk of developing iris neovascularization and neovascular glaucoma took the natural course. Although these results may be due to the overall bad prognosis of these particular ischemic eyes, the number of postoperative complications is unacceptably high. |
---|---|
AbstractList | Purpose Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent is injected directly into a cannulated retinal vein after pars plana vitrectomy. Design Prospective interventional case series. Participants Thirteen strictly defined patients with ischemic CRVO. Methods Patients with a decimal visual acuity (VA) of 0.2 or worse were scheduled for surgery within the first 5 months after onset of CRVO. A full ocular examination, determination of VA (Early Treatment Diabetic Retinopathy Study charts), and fluorescein angiography were done preoperatively and 6, 12, 26, and 52 weeks postoperatively. Main Outcome Measure Visual acuity 1 year after retinal endovascular lysis. Secondary study end points were (1) correlation of VA and successful recombinant tissue plasminogen activator injection into a retinal vein, (2) complication rate, and (3) number of additional surgical procedures within the first year after retinal endovascular lysis. Results All patients had an ischemic CRVO and completed the 1-year follow-up visit. Preoperative decimal VA was 0.063 +0.025/−0.018 (VA range, light perception [LP]–0.2); 6-week postoperative VA, 0.049 +0.024/−0.016 (LP–0.4); 3-month postoperative VA, 0.043 +0.019/−0.014 (LP–0.3); 6-month postoperative VA, 0.035 +0.022/−0.013 (blindness–0.4); and 12-month postoperative VA, 0.04 +0.026/−0.016 (blindness–0.4). Visual acuity changed 1 year after retinal endovascular lysis by −1.923±1.619 lines (+6 to −16 lines; P = 0.258). We considered the retinal endovascular lysis procedure to have been technically successful in 10 eyes. Visual changes did not depend on successful lysis. Six eyes developed neovascular glaucoma, of which 2 globes ended up with painful phthisis and had to be removed. Retinal detachment was found in 3 eyes and cataract in 4. Together, the 13 eyes needed 22 additional surgical procedures. Preoperative and postoperative angiographic examinations showed no significant changes. Conclusion Ischemic CRVO patients did not profit from retinal endovascular lysis in this pilot study. Visual results and the risk of developing iris neovascularization and neovascular glaucoma took the natural course. Although these results may be due to the overall bad prognosis of these particular ischemic eyes, the number of postoperative complications is unacceptably high. Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent is injected directly into a cannulated retinal vein after pars plana vitrectomy. Prospective interventional case series. Thirteen strictly defined patients with ischemic CRVO. Patients with a decimal visual acuity (VA) of 0.2 or worse were scheduled for surgery within the first 5 months after onset of CRVO. A full ocular examination, determination of VA (Early Treatment Diabetic Retinopathy Study charts), and fluorescein angiography were done preoperatively and 6, 12, 26, and 52 weeks postoperatively. Visual acuity 1 year after retinal endovascular lysis. Secondary study end points were (1) correlation of VA and successful recombinant tissue plasminogen activator injection into a retinal vein, (2) complication rate, and (3) number of additional surgical procedures within the first year after retinal endovascular lysis. All patients had an ischemic CRVO and completed the 1-year follow-up visit. Preoperative decimal VA was 0.063 +0.025/−0.018 (VA range, light perception [LP]–0.2); 6-week postoperative VA, 0.049 +0.024/−0.016 (LP–0.4); 3-month postoperative VA, 0.043 +0.019/−0.014 (LP–0.3); 6-month postoperative VA, 0.035 +0.022/−0.013 (blindness–0.4); and 12-month postoperative VA, 0.04 +0.026/−0.016 (blindness–0.4). Visual acuity changed 1 year after retinal endovascular lysis by −1.923±1.619 lines (+6 to −16 lines; P = 0.258). We considered the retinal endovascular lysis procedure to have been technically successful in 10 eyes. Visual changes did not depend on successful lysis. Six eyes developed neovascular glaucoma, of which 2 globes ended up with painful phthisis and had to be removed. Retinal detachment was found in 3 eyes and cataract in 4. Together, the 13 eyes needed 22 additional surgical procedures. Preoperative and postoperative angiographic examinations showed no significant changes. Ischemic CRVO patients did not profit from retinal endovascular lysis in this pilot study. Visual results and the risk of developing iris neovascularization and neovascular glaucoma took the natural course. Although these results may be due to the overall bad prognosis of these particular ischemic eyes, the number of postoperative complications is unacceptably high. |
Author | Junker, Bernd, MD Feltgen, Nicolas, MD Hansen, Lutz L., MD Agostini, Hansjuergen, MD |
Author_xml | – sequence: 1 fullname: Feltgen, Nicolas, MD – sequence: 2 fullname: Junker, Bernd, MD – sequence: 3 fullname: Agostini, Hansjuergen, MD – sequence: 4 fullname: Hansen, Lutz L., MD |
BookMark | eNqVkN1Kw0AQhRepYFt9Ay_yAon7l78bQUrVQqHg3-2ymUzoxnRTdtNC395Nqw8gDMzFnHPm8M3IxPYWCblnNGGUZQ9t0u-3w1YnnNIsOY-8IlOWyjKWORMTMg0yFmeS0xsy876lQZgJOSXLNxyM1V20tHV_1B4OnXbR-uSNj4yNVh62uDMQLdAOLsj-5F8YrhuA7uBNb2_JdaM7j3e_e04-n5cfi9d4vXlZLZ7WMfBQKc4KLMPnOhWyxAJ5FUo0acFzkUNdaWQCM6gqLoCmgrK6ocDzguZN0ZQSMy7mRF5ywfXeO2zU3pmddifFqBpRqFZdUKgRhTqPDLbHiw1Dt6NBpzwYtIC1cQiDqnvz3wDojDWgu288oW_7gwtQvGLKc0XV-0h7hE0zylialuIHaQ1_XQ |
CitedBy_id | crossref_primary_10_1097_IAE_0b013e3181a46a5e crossref_primary_10_1111_aos_13358 crossref_primary_10_1038_s41433_024_03149_3 crossref_primary_10_22608_APO_2017442 crossref_primary_10_1142_S2424905X18400056 crossref_primary_10_12677_HJO_2015_44015 crossref_primary_10_1016_j_survophthal_2018_04_005 crossref_primary_10_1007_s10439_018_2053_3 crossref_primary_10_1016_j_survophthal_2010_11_006 crossref_primary_10_1007_s00347_007_1508_y crossref_primary_10_1111_j_1755_3768_2007_01144_x crossref_primary_10_1111_aos_14480 crossref_primary_10_3109_08820538_2013_796394 crossref_primary_10_1007_s00340_010_3910_4 crossref_primary_10_1097_IAE_0b013e318241ae55 crossref_primary_10_1186_s12886_016_0282_5 crossref_primary_10_1586_17469899_2014_948423 crossref_primary_10_1016_j_ophtha_2007_06_010 crossref_primary_10_1136_bjophthalmol_2016_309190 crossref_primary_10_1111_aos_12830 crossref_primary_10_1007_s11548_011_0602_4 crossref_primary_10_4236_ojoph_2019_92009 crossref_primary_10_1007_s00417_017_3763_1 crossref_primary_10_5318_wjo_v4_i4_92 crossref_primary_10_1007_s11548_018_1850_3 crossref_primary_10_1097_IAE_0b013e3181a3b870 crossref_primary_10_1007_s40123_012_0003_y crossref_primary_10_1097_ICU_0b013e3283524148 |
Cites_doi | 10.1167/iovs.05-0981 10.1159/000027374 10.1016/S0002-9394(98)00086-5 10.1136/bjo.81.8.698 10.1016/S0161-6420(82)34655-2 10.1097/00006982-200507000-00014 10.1001/archopht.1997.01100150488006 10.1038/ki.1989.80 10.1136/bmj.1.6009.550 10.1016/S0161-6420(02)01192-2 10.1016/S0161-6420(86)33751-5 10.1136/bjo.69.2.108 10.3928/1081-597X-19970701-16 10.1159/000027455 10.3928/1542-8877-19990601-04 10.1097/00006982-200110000-00002 10.1016/S0002-9394(02)02030-5 10.1159/000310023 10.1001/archopht.1993.01090080083022 10.1159/000068980 10.1016/j.preteyeres.2004.12.001 10.1136/bjo.84.6.609 10.1016/S0161-6420(01)00875-2 10.1016/S0002-9394(14)76979-X 10.1007/BF00176435 10.1007/BF00920022 10.1136/bjo.84.12.1387 |
ContentType | Journal Article |
Copyright | American Academy of Ophthalmology 2007 American Academy of Ophthalmology |
Copyright_xml | – notice: American Academy of Ophthalmology – notice: 2007 American Academy of Ophthalmology |
DBID | AAYXX CITATION |
DOI | 10.1016/j.ophtha.2006.06.064 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 723.e1 |
ExternalDocumentID | 10_1016_j_ophtha_2006_06_064 S0161642006011559 1_s2_0_S0161642006011559 |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ACGFO ACGFS ACIUM ACNCT ADMUD ADPAM AEFWE AENEX AEVXI AFFNX AFJKZ AFRHN AFTJW AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CS3 DU5 EBS EFJIC EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ~ P2P R2- RIG ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION |
ID | FETCH-LOGICAL-c2064-68e9000d5349e8e2b066f582737cdbae13e6cbb23c05301df0c27807f8f94e623 |
ISSN | 0161-6420 |
IngestDate | Thu Sep 26 18:54:20 EDT 2024 Fri Feb 23 02:29:49 EST 2024 Tue Oct 15 22:54:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2064-68e9000d5349e8e2b066f582737cdbae13e6cbb23c05301df0c27807f8f94e623 |
ParticipantIDs | crossref_primary_10_1016_j_ophtha_2006_06_064 elsevier_sciencedirect_doi_10_1016_j_ophtha_2006_06_064 elsevier_clinicalkeyesjournals_1_s2_0_S0161642006011559 |
PublicationCentury | 2000 |
PublicationDate | 2007 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – year: 2007 text: 2007 |
PublicationDecade | 2000 |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationYear | 2007 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Hansen, Wiek, Schade (bib5) 1989; 199 Paques, Vallee, Herbreteau (bib15) 2000; 84 Bynoe, Weiss (bib27) 2003; 135 Williamson (bib3) 1997; 81 Hattenbach, Wellermann, Steinkamp (bib14) 1999; 213 Hayreh (bib1) 1994; 42 Cotran, Pober (bib29) 1989; 35 Elman (bib13) 1996; 94 Glacet-Bernard, Kuhn, Vine (bib17) 2000; 84 Green, Chan, Hutchins, Terry (bib11) 1981; 1 Lahey, Fong, Kearney (bib16) 1999; 30 Magargal, Donoso, Sanborn (bib21) 1982; 89 Wolf, Arend, Bertram (bib6) 1994; 232 Hayreh, Klugman, Beri (bib22) 1990; 228 Weiss (bib8) 1998; 126 Hayreh (bib30) 2002; 109 Bynoe, Hutchins, Lazarus, Friedberg (bib20) 2005; 25 Hansen, Danisevskis, Arntz (bib4) 1985; 69 Kohner, Pettit, Hamilton (bib12) 1976; 1 Quinlan, Elman, Bhatt (bib28) 1990; 110 (bib23) 1997; 115 Hattenbach, Steinkamp, Scharrer, Ohrloff (bib10) 1998; 212 Hayreh (bib7) 2003; 217 Hayreh (bib2) 2005; 24 Elman, Raden, Carrigan (bib18) 2001; 108 Servais, Thompson, Hayreh (bib24) 1986; 93 Schulze-Bonsel, Feltgen, Burau (bib26) 2006; 47 Holladay (bib25) 1997; 13 Weiss, Bynoe (bib19) 2001; 108 (bib32) 1993; 111 Opremcak, Bruce, Lomeo (bib9) 2001; 21 Seitz (bib31) 1962; 40 Magargal (10.1016/j.ophtha.2006.06.064_bib21) 1982; 89 Weiss (10.1016/j.ophtha.2006.06.064_bib8) 1998; 126 Quinlan (10.1016/j.ophtha.2006.06.064_bib28) 1990; 110 Wolf (10.1016/j.ophtha.2006.06.064_bib6) 1994; 232 Elman (10.1016/j.ophtha.2006.06.064_bib13) 1996; 94 Hayreh (10.1016/j.ophtha.2006.06.064_bib30) 2002; 109 Opremcak (10.1016/j.ophtha.2006.06.064_bib9) 2001; 21 Bynoe (10.1016/j.ophtha.2006.06.064_bib27) 2003; 135 Hattenbach (10.1016/j.ophtha.2006.06.064_bib10) 1998; 212 Seitz (10.1016/j.ophtha.2006.06.064_bib31) 1962; 40 Glacet-Bernard (10.1016/j.ophtha.2006.06.064_bib17) 2000; 84 Weiss (10.1016/j.ophtha.2006.06.064_bib19) 2001; 108 Elman (10.1016/j.ophtha.2006.06.064_bib18) 2001; 108 (10.1016/j.ophtha.2006.06.064_bib23) 1997; 115 Hayreh (10.1016/j.ophtha.2006.06.064_bib2) 2005; 24 Bynoe (10.1016/j.ophtha.2006.06.064_bib20) 2005; 25 Williamson (10.1016/j.ophtha.2006.06.064_bib3) 1997; 81 Paques (10.1016/j.ophtha.2006.06.064_bib15) 2000; 84 Hayreh (10.1016/j.ophtha.2006.06.064_bib1) 1994; 42 Hayreh (10.1016/j.ophtha.2006.06.064_bib22) 1990; 228 Hansen (10.1016/j.ophtha.2006.06.064_bib4) 1985; 69 Schulze-Bonsel (10.1016/j.ophtha.2006.06.064_bib26) 2006; 47 Hayreh (10.1016/j.ophtha.2006.06.064_bib7) 2003; 217 Cotran (10.1016/j.ophtha.2006.06.064_bib29) 1989; 35 Holladay (10.1016/j.ophtha.2006.06.064_bib25) 1997; 13 Hansen (10.1016/j.ophtha.2006.06.064_bib5) 1989; 199 Lahey (10.1016/j.ophtha.2006.06.064_bib16) 1999; 30 Servais (10.1016/j.ophtha.2006.06.064_bib24) 1986; 93 (10.1016/j.ophtha.2006.06.064_bib32) 1993; 111 Green (10.1016/j.ophtha.2006.06.064_bib11) 1981; 1 Hattenbach (10.1016/j.ophtha.2006.06.064_bib14) 1999; 213 Kohner (10.1016/j.ophtha.2006.06.064_bib12) 1976; 1 |
References_xml | – volume: 69 start-page: 108 year: 1985 end-page: 116 ident: bib4 article-title: A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation publication-title: Br J Ophthalmol contributor: fullname: Arntz – volume: 21 start-page: 408 year: 2001 end-page: 415 ident: bib9 article-title: Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases publication-title: Retina contributor: fullname: Lomeo – volume: 109 start-page: 1758 year: 2002 end-page: 1761 ident: bib30 article-title: t-PA in CRVO publication-title: Ophthalmology contributor: fullname: Hayreh – volume: 84 start-page: 1387 year: 2000 end-page: 1391 ident: bib15 article-title: Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion publication-title: Br J Ophthalmol contributor: fullname: Herbreteau – volume: 228 start-page: 201 year: 1990 end-page: 217 ident: bib22 article-title: Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase publication-title: Graefes Arch Clin Exp Ophthalmol contributor: fullname: Beri – volume: 126 start-page: 142 year: 1998 end-page: 144 ident: bib8 article-title: Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein publication-title: Am J Ophthalmol contributor: fullname: Weiss – volume: 1 start-page: 550 year: 1976 end-page: 553 ident: bib12 article-title: Streptokinase in central retinal vein occlusion: a controlled clinical trial publication-title: Br Med J contributor: fullname: Hamilton – volume: 35 start-page: 969 year: 1989 end-page: 975 ident: bib29 article-title: Effects of cytokines on vascular endothelium: their role in vascular and immune injury publication-title: Kidney Int contributor: fullname: Pober – volume: 115 start-page: 486 year: 1997 end-page: 491 ident: bib23 article-title: Natural history and clinical management of central retinal vein occlusion publication-title: Arch Ophthalmol – volume: 40 start-page: 1 year: 1962 end-page: 175 ident: bib31 article-title: The retinal blood vessels publication-title: Buch Augenarzt contributor: fullname: Seitz – volume: 89 start-page: 1241 year: 1982 end-page: 1245 ident: bib21 article-title: Retinal ischemia and risk of neovascularization following central retinal vein obstruction publication-title: Ophthalmology contributor: fullname: Sanborn – volume: 42 start-page: 109 year: 1994 end-page: 132 ident: bib1 article-title: Retinal vein occlusion publication-title: Indian J Ophthalmol contributor: fullname: Hayreh – volume: 217 start-page: 167 year: 2003 end-page: 188 ident: bib7 article-title: Management of central retinal vein occlusion publication-title: Ophthalmologica contributor: fullname: Hayreh – volume: 93 start-page: 301 year: 1986 end-page: 303 ident: bib24 article-title: Relative afferent pupillary defect in central retinal vein occlusion publication-title: Ophthalmology contributor: fullname: Hayreh – volume: 232 start-page: 33 year: 1994 end-page: 39 ident: bib6 article-title: Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study publication-title: Graefes Arch Clin Exp Ophthalmol contributor: fullname: Bertram – volume: 212 start-page: 394 year: 1998 end-page: 398 ident: bib10 article-title: Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion publication-title: Ophthalmologica contributor: fullname: Ohrloff – volume: 110 start-page: 118 year: 1990 end-page: 123 ident: bib28 article-title: The natural course of central retinal vein occlusion publication-title: Am J Ophthalmol contributor: fullname: Bhatt – volume: 47 start-page: 1236 year: 2006 end-page: 1240 ident: bib26 article-title: Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburger visual acuity test publication-title: Invest Ophthalmol Vis Sci contributor: fullname: Burau – volume: 30 start-page: 427 year: 1999 end-page: 434 ident: bib16 article-title: Intravitreal tissue plasminogen activator for acute central retinal vein occlusion publication-title: Ophthalmic Surg Lasers contributor: fullname: Kearney – volume: 81 start-page: 698 year: 1997 end-page: 704 ident: bib3 article-title: Central retinal vein occlusion: what’s the story? publication-title: Br J Ophthalmol contributor: fullname: Williamson – volume: 1 start-page: 27 year: 1981 end-page: 55 ident: bib11 article-title: Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases publication-title: Retina contributor: fullname: Terry – volume: 94 start-page: 471 year: 1996 end-page: 504 ident: bib13 article-title: Thrombolytic therapy for central retinal vein occlusion: results of a pilot study publication-title: Trans Am Ophthalmol Soc contributor: fullname: Elman – volume: 24 start-page: 493 year: 2005 end-page: 519 ident: bib2 article-title: Prevalent misconceptions about acute retinal vascular occlusive disorders publication-title: Prog Retin Eye Res contributor: fullname: Hayreh – volume: 213 start-page: 360 year: 1999 end-page: 366 ident: bib14 article-title: Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion publication-title: Ophthalmologica contributor: fullname: Steinkamp – volume: 13 start-page: 388 year: 1997 end-page: 391 ident: bib25 article-title: Proper method for calculating average visual acuity publication-title: J Refract Surg contributor: fullname: Holladay – volume: 108 start-page: 219 year: 2001 end-page: 221 ident: bib18 article-title: Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion publication-title: Trans Am Ophthalmol Soc contributor: fullname: Carrigan – volume: 199 start-page: 90 year: 1989 end-page: 99 ident: bib5 article-title: Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion publication-title: Ophthalmologica contributor: fullname: Schade – volume: 25 start-page: 625 year: 2005 end-page: 632 ident: bib20 article-title: Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons publication-title: Retina contributor: fullname: Friedberg – volume: 108 start-page: 2249 year: 2001 end-page: 2257 ident: bib19 article-title: Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion publication-title: Ophthalmology contributor: fullname: Bynoe – volume: 111 start-page: 1087 year: 1993 end-page: 1095 ident: bib32 article-title: Baseline and early natural history report: the Central Vein Occlusion Study publication-title: Arch Ophthalmol – volume: 135 start-page: 382 year: 2003 end-page: 384 ident: bib27 article-title: Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults publication-title: Am J Ophthalmol contributor: fullname: Weiss – volume: 84 start-page: 609 year: 2000 end-page: 613 ident: bib17 article-title: Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study publication-title: Br J Ophthalmol contributor: fullname: Vine – volume: 47 start-page: 1236 year: 2006 ident: 10.1016/j.ophtha.2006.06.064_bib26 article-title: Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburger visual acuity test publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0981 contributor: fullname: Schulze-Bonsel – volume: 212 start-page: 394 year: 1998 ident: 10.1016/j.ophtha.2006.06.064_bib10 article-title: Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion publication-title: Ophthalmologica doi: 10.1159/000027374 contributor: fullname: Hattenbach – volume: 126 start-page: 142 year: 1998 ident: 10.1016/j.ophtha.2006.06.064_bib8 article-title: Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(98)00086-5 contributor: fullname: Weiss – volume: 40 start-page: 1 year: 1962 ident: 10.1016/j.ophtha.2006.06.064_bib31 article-title: The retinal blood vessels publication-title: Buch Augenarzt contributor: fullname: Seitz – volume: 94 start-page: 471 year: 1996 ident: 10.1016/j.ophtha.2006.06.064_bib13 article-title: Thrombolytic therapy for central retinal vein occlusion: results of a pilot study publication-title: Trans Am Ophthalmol Soc contributor: fullname: Elman – volume: 81 start-page: 698 year: 1997 ident: 10.1016/j.ophtha.2006.06.064_bib3 article-title: Central retinal vein occlusion: what’s the story? publication-title: Br J Ophthalmol doi: 10.1136/bjo.81.8.698 contributor: fullname: Williamson – volume: 89 start-page: 1241 year: 1982 ident: 10.1016/j.ophtha.2006.06.064_bib21 article-title: Retinal ischemia and risk of neovascularization following central retinal vein obstruction publication-title: Ophthalmology doi: 10.1016/S0161-6420(82)34655-2 contributor: fullname: Magargal – volume: 25 start-page: 625 year: 2005 ident: 10.1016/j.ophtha.2006.06.064_bib20 article-title: Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons publication-title: Retina doi: 10.1097/00006982-200507000-00014 contributor: fullname: Bynoe – volume: 115 start-page: 486 year: 1997 ident: 10.1016/j.ophtha.2006.06.064_bib23 article-title: Natural history and clinical management of central retinal vein occlusion publication-title: Arch Ophthalmol doi: 10.1001/archopht.1997.01100150488006 – volume: 35 start-page: 969 year: 1989 ident: 10.1016/j.ophtha.2006.06.064_bib29 article-title: Effects of cytokines on vascular endothelium: their role in vascular and immune injury publication-title: Kidney Int doi: 10.1038/ki.1989.80 contributor: fullname: Cotran – volume: 1 start-page: 550 year: 1976 ident: 10.1016/j.ophtha.2006.06.064_bib12 article-title: Streptokinase in central retinal vein occlusion: a controlled clinical trial publication-title: Br Med J doi: 10.1136/bmj.1.6009.550 contributor: fullname: Kohner – volume: 109 start-page: 1758 year: 2002 ident: 10.1016/j.ophtha.2006.06.064_bib30 article-title: t-PA in CRVO publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01192-2 contributor: fullname: Hayreh – volume: 93 start-page: 301 year: 1986 ident: 10.1016/j.ophtha.2006.06.064_bib24 article-title: Relative afferent pupillary defect in central retinal vein occlusion publication-title: Ophthalmology doi: 10.1016/S0161-6420(86)33751-5 contributor: fullname: Servais – volume: 69 start-page: 108 year: 1985 ident: 10.1016/j.ophtha.2006.06.064_bib4 article-title: A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation publication-title: Br J Ophthalmol doi: 10.1136/bjo.69.2.108 contributor: fullname: Hansen – volume: 13 start-page: 388 year: 1997 ident: 10.1016/j.ophtha.2006.06.064_bib25 article-title: Proper method for calculating average visual acuity publication-title: J Refract Surg doi: 10.3928/1081-597X-19970701-16 contributor: fullname: Holladay – volume: 213 start-page: 360 year: 1999 ident: 10.1016/j.ophtha.2006.06.064_bib14 article-title: Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion publication-title: Ophthalmologica doi: 10.1159/000027455 contributor: fullname: Hattenbach – volume: 30 start-page: 427 year: 1999 ident: 10.1016/j.ophtha.2006.06.064_bib16 article-title: Intravitreal tissue plasminogen activator for acute central retinal vein occlusion publication-title: Ophthalmic Surg Lasers doi: 10.3928/1542-8877-19990601-04 contributor: fullname: Lahey – volume: 42 start-page: 109 year: 1994 ident: 10.1016/j.ophtha.2006.06.064_bib1 article-title: Retinal vein occlusion publication-title: Indian J Ophthalmol contributor: fullname: Hayreh – volume: 1 start-page: 27 year: 1981 ident: 10.1016/j.ophtha.2006.06.064_bib11 article-title: Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases publication-title: Retina contributor: fullname: Green – volume: 21 start-page: 408 year: 2001 ident: 10.1016/j.ophtha.2006.06.064_bib9 article-title: Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases publication-title: Retina doi: 10.1097/00006982-200110000-00002 contributor: fullname: Opremcak – volume: 135 start-page: 382 year: 2003 ident: 10.1016/j.ophtha.2006.06.064_bib27 article-title: Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(02)02030-5 contributor: fullname: Bynoe – volume: 199 start-page: 90 year: 1989 ident: 10.1016/j.ophtha.2006.06.064_bib5 article-title: Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion publication-title: Ophthalmologica doi: 10.1159/000310023 contributor: fullname: Hansen – volume: 111 start-page: 1087 year: 1993 ident: 10.1016/j.ophtha.2006.06.064_bib32 article-title: Baseline and early natural history report: the Central Vein Occlusion Study publication-title: Arch Ophthalmol doi: 10.1001/archopht.1993.01090080083022 – volume: 217 start-page: 167 year: 2003 ident: 10.1016/j.ophtha.2006.06.064_bib7 article-title: Management of central retinal vein occlusion publication-title: Ophthalmologica doi: 10.1159/000068980 contributor: fullname: Hayreh – volume: 24 start-page: 493 year: 2005 ident: 10.1016/j.ophtha.2006.06.064_bib2 article-title: Prevalent misconceptions about acute retinal vascular occlusive disorders publication-title: Prog Retin Eye Res doi: 10.1016/j.preteyeres.2004.12.001 contributor: fullname: Hayreh – volume: 84 start-page: 609 year: 2000 ident: 10.1016/j.ophtha.2006.06.064_bib17 article-title: Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study publication-title: Br J Ophthalmol doi: 10.1136/bjo.84.6.609 contributor: fullname: Glacet-Bernard – volume: 108 start-page: 219 year: 2001 ident: 10.1016/j.ophtha.2006.06.064_bib18 article-title: Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion publication-title: Trans Am Ophthalmol Soc contributor: fullname: Elman – volume: 108 start-page: 2249 year: 2001 ident: 10.1016/j.ophtha.2006.06.064_bib19 article-title: Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion publication-title: Ophthalmology doi: 10.1016/S0161-6420(01)00875-2 contributor: fullname: Weiss – volume: 110 start-page: 118 year: 1990 ident: 10.1016/j.ophtha.2006.06.064_bib28 article-title: The natural course of central retinal vein occlusion publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)76979-X contributor: fullname: Quinlan – volume: 232 start-page: 33 year: 1994 ident: 10.1016/j.ophtha.2006.06.064_bib6 article-title: Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/BF00176435 contributor: fullname: Wolf – volume: 228 start-page: 201 year: 1990 ident: 10.1016/j.ophtha.2006.06.064_bib22 article-title: Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/BF00920022 contributor: fullname: Hayreh – volume: 84 start-page: 1387 year: 2000 ident: 10.1016/j.ophtha.2006.06.064_bib15 article-title: Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion publication-title: Br J Ophthalmol doi: 10.1136/bjo.84.12.1387 contributor: fullname: Paques |
SSID | ssj0006634 |
Score | 1.8716763 |
Snippet | Purpose Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent... Retinal endovascular lysis is a new therapeutic option for patients with central retinal vein occlusion (CRVO). In this procedure, a fibrinolytic agent is... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 716 |
SubjectTerms | Ophthalmology |
Title | Retinal Endovascular Lysis in Ischemic Central Retinal Vein Occlusion |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0161642006011559 https://dx.doi.org/10.1016/j.ophtha.2006.06.064 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZCmMvY5-s-0IPews2tmxLzmM3Wro1XaG0W9-EJcttQ6qUxn7py_71nb4cdwtlHRgTHMeRdT_dnU6_OyH0SRCYSFdNFbFUJlFekmlUNZRGmcjBWBofgZp858PvdP80_3ZWnI1Gvwaspa4VsbzdmFfyP1KFayBXkyX7AMn2D4UL8BnkC2eQMJz_ScbHJl_ZFAbW9ZpSOrM1Ri715CtMXC313UdwJ-H2Hwq-PZJy0a2CVLx7enR90V5UiytXmMlGF_yGWo5ir3U8CB3sqUV77tSWBVS1piN22rM1PqsbXfeoOl-CRtFuo2ywkfPO5n6utaD28aBZ195OZvGdkAQbxidpGsGUJrmjYF2aqEdSPlCXLKUDy8tIFqt0o153IYZ5vLTd4NeQzJGv7VhYu__DvPWkw8Bnm3P3FLMDJ-X2yB-hLQKaqRijrZ2D458HvTEHh8yXh3fvFbIvLUXw79Zs9m4GHsvJM_TUTzXwjsPNczRS-gV6fOjJFC_RrscDHsIHW_jgS40DfLCHDw63G_jgHj6v0One7smX_cjvqhFJAi2MaKnMRrF1keVTVSoi4B2booSRyWQtKpVmikoBY1iCfk7SukkkYWXCmrKZ5gq85ddorJdavUEYjGUpCtkIamgBSTPNMkWoyLKyEIwoto2i0Bv82hVP4fdJYRux0GU8JAaDKVMrP-ZWPOUrwhNDSaSpEYepJmQW1oe_9K6jcwk5IOje_3z7wDa-Q09ceN9E4d6jcXvTqQ_gl7bio8fObzzbjN4 |
link.rule.ids | 315,786,790,4038,27945,27946,27947 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+Endovascular+Lysis+in+Ischemic+Central+Retinal+Vein+Occlusion&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Feltgen%2C+Nicolas&rft.au=Junker%2C+Bernd&rft.au=Agostini%2C+Hansjuergen&rft.au=Hansen%2C+Lutz+L.&rft.date=2007&rft.issn=0161-6420&rft.volume=114&rft.issue=4&rft.spage=716&rft.epage=723.e1&rft_id=info:doi/10.1016%2Fj.ophtha.2006.06.064&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ophtha_2006_06_064 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642007X01258%2Fcov150h.gif |